248 related articles for article (PubMed ID: 14610243)
1. Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
Salavaggione OE; Yang C; Kidd LB; Thomae BA; Pankratz VS; Trepanier LA; Weinshilboum RM
J Pharmacol Exp Ther; 2004 Feb; 308(2):617-26. PubMed ID: 14610243
[TBL] [Abstract][Full Text] [Related]
2. Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
Salavaggione OE; Kidd L; Prondzinski JL; Szumlanski CL; Pankratz VS; Wang L; Trepanier L; Weinshilboum RM
Pharmacogenetics; 2002 Dec; 12(9):713-24. PubMed ID: 12464800
[TBL] [Abstract][Full Text] [Related]
3. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.
Szumlanski CL; Honchel R; Scott MC; Weinshilboum RM
Pharmacogenetics; 1992 Aug; 2(4):148-59. PubMed ID: 1306116
[TBL] [Abstract][Full Text] [Related]
4. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.
Milek M; Murn J; Jaksic Z; Lukac Bajalo J; Jazbec J; Mlinaric Rascan I
Pharmacology; 2006; 77(3):105-14. PubMed ID: 16691038
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1.
Lee D; Szumlanski C; Houtman J; Honchel R; Rojas K; Overhauser J; Wieben ED; Weinshilboum RM
Drug Metab Dispos; 1995 Mar; 23(3):398-405. PubMed ID: 7628307
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of human erythrocyte thiopurine methyltransferase activity in a French population.
Tinel M; Berson A; Pessayre D; Letteron P; Cattoni MP; Horsmans Y; Larrey D
Br J Clin Pharmacol; 1991 Dec; 32(6):729-34. PubMed ID: 1768566
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.
Loennechen T; Yates CR; Fessing MY; Relling MV; Krynetski EY; Evans WE
Clin Pharmacol Ther; 1998 Jul; 64(1):46-51. PubMed ID: 9695718
[TBL] [Abstract][Full Text] [Related]
10. Human pharmacogenetics of methyl conjugation.
Weinshilboum RM
Fed Proc; 1984 May; 43(8):2303-7. PubMed ID: 6714437
[TBL] [Abstract][Full Text] [Related]
11. Segregation analysis of human red blood cell thiopurine methyltransferase activity.
Vuchetich JP; Weinshilboum RM; Price RA
Genet Epidemiol; 1995; 12(1):1-11. PubMed ID: 7713396
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
Wang L; Weinshilboum R
Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism.
Szumlanski C; Otterness D; Her C; Lee D; Brandriff B; Kelsell D; Spurr N; Lennard L; Wieben E; Weinshilboum R
DNA Cell Biol; 1996 Jan; 15(1):17-30. PubMed ID: 8561894
[TBL] [Abstract][Full Text] [Related]
14. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine methyltransferase activity in a Korean population sample of children.
Park-Hah JO; Klemetsdal B; Lysaa R; Choi KH; Aarbakke J
Clin Pharmacol Ther; 1996 Jul; 60(1):68-74. PubMed ID: 8689814
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Coulthard SA; Matheson EC; Hall AG; Hogarth LA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype.
Arenas M; Duley JA; Ansari A; Shobowale-Bakre EA; Fairbanks L; Soon SY; Sanderson J; Marinaki AM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1403-5. PubMed ID: 15571267
[TBL] [Abstract][Full Text] [Related]
19. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis.
Spire-Vayron de la Moureyre C; Debuysère H; Sabbagh N; Marez D; Vinner E; Chevalier ED; Lo Guidice JM; Broly F
Hum Mutat; 1998; 12(3):177-85. PubMed ID: 9711875
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.
Larussa T; Suraci E; Lentini M; Nazionale I; Gallo L; Abenavoli L; Imeneo M; Costanzo FS; Cuda G; Luzza F
Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
